Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
31.33
+0.77 (2.52%)
Mar 17, 2026, 2:09 PM EDT - Market open
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts that cover Capricor Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $44.63, which forecasts a 42.45% increase in the stock price over the next year. The lowest target is $13 and the highest is $63.
Price Target: $44.63 (+42.45%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 5 | 5 | 5 | 5 |
| Buy | 3 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $50 → $63 | Strong Buy | Maintains | $50 → $63 | +101.09% | Mar 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $45 → $58 | Buy | Reiterates | $45 → $58 | +85.13% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +91.51% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +91.51% | Mar 10, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $50 | Strong Buy | Reiterates | $21 → $50 | +59.59% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
106.54M
Revenue Next Year
140.48M
from 106.54M
Increased by 31.86%
EPS This Year
-1.57
from -2.26
EPS Next Year
0.08
from -1.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 267.8M | 227.5M | |||
| Avg | 106.5M | 140.5M | |||
| Low | n/a | 62.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 113.5% | |||
| Avg | - | 31.9% | |||
| Low | - | -41.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.84 | 0.35 | |||
| Avg | -1.57 | 0.08 | |||
| Low | -2.31 | -0.12 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.